Abstract:Various pathological characteristics of autism spectrum disorder (ASD) stem from abnormalities in brain resident immune cells, specifically microglia, to prune unnecessary synapses or neural connections during early development. Animal models of ASD exhibit an abundance of synapses in different brain regions, which is strongly linked to the appearance of ASD behaviors. Overexpression of CD47 on neurons acts as a “don’t eat me” signal, safeguarding synapses from inappropriate pruning by microglia. Indeed, CD47 overexpression occurs in 16p11.2 deletion carriers, causing decreased synaptic phagocytosis and the manifestation of ASD characteristics. However, the role of CD47 in synaptic pruning impairment leading to ASD phenotypes in the 16p11.2 deletion mouse model is unclear. Moreover, whether blocking CD47 can alleviate ASD mice’s behavioral deficits remains unknown. Here, we demonstrate a strong link between increased CD47 expression, decreased microglia phagocytosis capacity, and increased impairment in social novelty preference in the 16p11.2 deletion mice. The reduction in microglia phagocytosis caused a rise in excitatory synapses and transmission in the prefrontal cortex of 16p11.2 deletion mice. Importantly, blocking CD47 using a specific CD47 antibody or reducing CD47 expression using a specific shRNA enhanced the microglia phagocytosis and reduced excitatory transmission. Reduction in CD47 expression improved social novelty preference deficits in 16p11.2 mice. These findings demonstrate that CD47 contributes to the ASD phenotypes in the 16p11.2 deletion mice and could be a promising target for the development of treatment for ASD. Significance Statement Autism spectrum disorder (ASD) is a neurological developmental condition characterized by stereotyped behaviors and cognitive deficits. However, therapeutic options for ASD remain limited. Activation of the classical complement system, an innate immune signaling pathway component, supports microglia-mediated synaptic pruning during development and disease. In particular, CD47, a “don’t eat me” signal, protects synapses from inappropriate clearance. Here, we investigated the role of CD47 in microglial phagocytosis using the 16p11.2 deletion mouse model, demonstrating that reducing CD47 signaling enhances microglial phagocytose synapses in the prefrontal cortex. This enhancement leads to improved synaptic function and reduced social behavioral deficits. These findings provide mechanistic insights into the role of CD47, laying the groundwork for developing more effective treatments for ASD. ### Competing Interest Statement The authors have declared no competing interest.

Roles of the Notch signaling pathway and microglia in autism

[Research Advances in the Role of Mtor Signaling Pathway in Autism Spectrum Disorder].

The Notch1/Hes1 pathway regulates Neuregulin 1/ErbB4 and participates in microglial activation in rats with VPA-induced autism

Microglia and astrocytes underlie neuroinflammation and synaptic susceptibility in autism spectrum disorder

Microglia Mediated Neuroinflammation in Autism Spectrum Disorder.

The Impact of Microglia on Neurodevelopment and Brain Function in Autism

Mechanism of action and therapeutic targeting of microglia in autism spectrum disorder

Microglia homeostasis mediated by epigenetic ARID1A regulates neural progenitor cells response and leads to autism-like behaviors

Microglial Dysfunction in Autism Spectrum Disorder

Glutaminase 1 Deficiency Confined in Forebrain Neurons Causes Autism Spectrum Disorder-Like Behaviors.

Notch signaling in the central nervous system with special reference to its expression in microglia.

Developmental Dopaminergic Signaling Modulates Neural Circuit Formation and Contributes to Autism Spectrum Disorder- Related Phenotypes

Microglial over-pruning of synapses during development in autism-associated SCN2A-deficient mice and human cerebral organoids

The Canonical Wnt Signaling Pathway in Autism.

Dopaminergic Signaling is Linked to Neurodevelopmental Deficits in Autism Spectrum Disorder (ASD)

Signalling pathways in autism spectrum disorder: mechanisms and therapeutic implications

Advances in the Understanding of the Pathology of Autism Focusing on Synapse Dysfunction

Unraveling the Role of Wnt Signaling Pathway in the Pathogenesis of Autism Spectrum Disorder (ASD): A Systematic Review

Microglial Tmem59 Deficiency Impairs Phagocytosis of Synapse and Leads to Autism-Like Behaviors in Mice

Autistic Spectrum Disorder (ASD) – Gene, Molecular and Pathway Signatures Linking Systemic Inflammation, Mitochondrial Dysfunction, Transsynaptic Signalling, and Neurodevelopment

The “don’t eat me” signal CD47 contributes to microglial phagocytosis defects and autism-like behaviors in 16p11.2 deletion mice